In a rat heart model of cardiopulmonary bypass and ischemic cardiac arrest the potential
additive protective effects of hypothermia and chemical cardioplegia have been …

This experimental study was undertaken to evaluate the hypothesis that cardioplegic arrest
at 37° C is superior to 10° C cardioplegic arrest in the myocardial protection of an acutely …

In clinical use cardioplegia is usually combined with local cardiac hypothermia, whose
powerful protective effects make it difficult to assess the contributions made by the …

Hypothermia combined with pharmacologic cardioplegia protects the globally ischemic adult
heart, but this benefit may not extend to children; poor postischemic recovery of function and …

Global ischemic arrest was induced in the canine myocardium under normothermic (35° to
37° C), hypothermic (8° to 12° C), and hypothermic plus cardioplegic conditions (30 mEq K+ …

The rationale for cold saline induced hypothermic myocardial protection during ischemic
cardioplegia has been limited for the most part to empiric and contractility observations. The …

This study was performed to determine if systemic temperature affects the rate of cooling and
rewarming of the myocardium between infusions of cold potassium cardioplegic solution …

A standard experimental protocol was developed to explore the role of hypothermia and
potassium cardioplegia in myocardial preservation during 120 minutes of ischemic arrest …

This study tests the hypothesis that the efficacy of hypothermia as a cardiacprotective agent
can be increased by adding the slow channel-blocking agent, nifedipine. Isolated …

Both single-dose and multidose cardioplegia are protective in the ischemic adult heart under
normothermic and hypothermic conditions, but in the hypothermic neonatal rabbit heart …